NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00409-6660-01 — Sodium chloride concentrate IV solutionAI (113 hospitals, 26,179–26,215 samples)
• NDC 00378-9072-93 — Rivastigmine 13.3 mg/24 hour skin patchAI (111 hospitals, 25,359–26,214 samples)
• NDC 00065-0246-10 — Betaxolol eye drops, 0.25% suspensionAI (265 hospitals, 25,316–26,198 samples)
• NDC 00990-7918-19 — Dextrose 70% intravenous solutionAI (340 hospitals, 25,945–26,188 samples)
• NDC 63323-0259-30 — Bacteriostatic saline solution for injectionAI (58 hospitals, 25,945–26,188 samples)
• NDC 63323-0924-30 — Bacteriostatic sodium chloride 30 mL injectionAI (171 hospitals, 25,945–26,188 samples)
• NDC 63323-0924-01 — Bacteriostatic saline injectionAI (127 hospitals, 25,945–26,188 samples)
• NDC 65862-0187-30 — Ondansetron 4 mg tabletAI (204 hospitals, 22,037–26,186 samples)
• NDC 409120910 — Lidocaine with epinephrine injection, 5 mL ampuleAI (70 hospitals, 26,063–26,180 samples)
• NDC 00093-4061-30 — Formoterol fumarate 20 mcg per 2 mL nebulizer solutionAI (46 hospitals, 25,275–26,175 samples)
• NDC 51079-0284-01 — Diazepam 2 mg tabletAI (697 hospitals, 25,444–26,173 samples)
• NDC 00168-0040-15 — BETAMETHASONE VALERATE 0.1 % TOPICAL CREAMAI (328 hospitals, 25,249–26,167 samples)
• NDC 00990-7111-09 — Potassium chloride in lactated Ringer's and dextrose IV solutionAI (338 hospitals, 25,130–26,165 samples)
• NDC 75834-0139-60 — Balsam Peru and castor oil ointmentAI (197 hospitals, 25,286–26,159 samples)
• NDC 00054-3185-44 — Diazepam 5 mg/mL oral concentrateAI (177 hospitals, 25,364–26,156 samples)
• NDC 00409-2596-03 — Midazolam 5 mg/mL injectionAI (219 hospitals, 22,933–26,155 samples)
• NDC 61314-0225-05 — Timolol 0.5% eye drops, 5 mL bottleAI (461 hospitals, 25,240–26,149 samples)
• NDC 00591-2258-04 — Scopolamine 1 mg transdermal patch (3-day)AI (101 hospitals, 25,139–26,147 samples)
• NDC 00904-6861-61 — Divalproex 500 mg delayed-release tabletAI (508 hospitals, 25,480–26,128 samples)
• NDC 76204-0600-05 — Ipratropium-albuterol inhalation solution, 3 mLAI (73 hospitals, 25,801–26,125 samples)
• NDC 00115-5211-16 — Colestipol 1 gram tabletsAI (311 hospitals, 25,582–26,122 samples)
• NDC 00430-3754-14 — Estrace vaginal estradiol creamAI (402 hospitals, 25,269–26,106 samples)
• NDC 51672-4048-01 — Clotrimazole and betamethasone topical creamAI (478 hospitals, 25,224–26,106 samples)
• NDC 60505-0560-01 — OFLOXACIN 0.3 % EYE DROPSAI (138 hospitals, 25,224–26,106 samples)
• NDC 68462-0564-17 — Mupirocin 2% cream, 15 g tubeAI (327 hospitals, 25,224–26,106 samples)
• NDC 51672-3007-01 — Hydrocortisone and acetic acid ear dropsAI (304 hospitals, 25,269–26,106 samples)
• NDC 00781-3232-95 — Pantoprazole 40 mg IV injectionAI (298 hospitals, 25,356–26,103 samples)
• NDC 65302-0501-05 — Neostigmine methylsulfate 5 mg/5 mL syringeAI (67 hospitals, 25,235–26,099 samples)
• NDC 50474-0804-03 — Rotigotine 4 mg 24-hour skin patch, box of 30AI (346 hospitals, 25,359–26,097 samples)
• NDC 67457-0665-20 — Posaconazole 300 mg intravenous solutionAI (118 hospitals, 25,241–26,087 samples)
• NDC 16714-0115-02 — Rivastigmine 4.6 mg/24 hour skin patchAI (108 hospitals, 25,221–26,076 samples)
• NDC 16714-0200-10 — Ondansetron 4 mg dissolving tabletAI (299 hospitals, 19,959–26,070 samples)
• NDC 63323-0368-20 — Ampicillin-sulbactam 1.5 g injectionAI (257 hospitals, 24,836–26,069 samples)
• NDC 70121-1399-01 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (43 hospitals, 24,912–26,064 samples)
• NDC 67850-0150-25 — Pantoprazole sodium 40 mg IV injectionAI (199 hospitals, 25,297–26,062 samples)
• NDC 00054-0062-58 — Citalopram oral liquid, 10 mg per 5 mLAI (317 hospitals, 25,229–26,057 samples)
• NDC 63739-0997-64 — Lidocaine 4% mucosal solutionAI (157 hospitals, 25,219–26,056 samples)
• NDC 24208-0819-05 — Timolol eye gel solutionAI (116 hospitals, 25,219–26,056 samples)
• NDC 08065-1831-50 — Sodium hyaluronate injectionAI (433 hospitals, 24,972–26,052 samples)
• NDC 60758-0908-10 — Polymyxin B and trimethoprim eye dropsAI (281 hospitals, 25,283–26,048 samples)
• NDC 00409-7101-69 — Sodium chloride 0.9% IV piggybackAI (213 hospitals, 25,193–26,048 samples)
• NDC 24201-0201-05 — Sodium tetradecyl sulfate 3% IV solutionAI (349 hospitals, 25,039–26,047 samples)
• NDC 68084-0221-11 — Ondansetron 8 mg tabletAI (179 hospitals, 22,004–26,045 samples)
• NDC 00093-2204-01 — metoclopramide 5 mg tabletAI (515 hospitals, 25,503–26,034 samples)
• NDC 00904-6557-61 — Extended-release morphine sulfate 15 mg tabletsAI (539 hospitals, 25,300–26,029 samples)
• NDC 00338-0663-04 — Potassium chloride in dextrose and saline IV solutionAI (434 hospitals, 24,785–26,027 samples)
• NDC 00338-1101-04 — Amino acid and dextrose intravenous solutionAI (286 hospitals, 25,324–26,026 samples)
• NDC 59762-5009-01 — clindamycin 2 % vaginal creamAI (354 hospitals, 25,115–26,024 samples)
• NDC 68084-0640-11 — Lithium carbonate extended-release 300 mg tabletAI (441 hospitals, 25,480–26,020 samples)
• NDC 24208-0353-05 — Loteprednol 0.2% eye drop suspension, 5 mL bottleAI (222 hospitals, 25,153–26,017 samples)